Journals / Marmara Pharmaceutical Journal / 2017 / Cilt: 21 - Sayı: 2

Investigation of inducible clindamycin resistance in methicillin resistant Staphylococcus aureus strains

Pages
407–411
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The D zone test, which can be done by using erythromycin and clindamycin discs, is a simple disc diffusion test for detection MLSB phenotype and clinical laboratories should report in vitro inducible clindamycin resistance in all S. aureus isolates.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Clindamycin is one of the important alternative antibiotics in the therapy of Staphylococcus aureus infections.
📊
Key Findings & Data:The aim of this study was to investigate the inducible clindamycin resistance of 86 MRSA strains isolated from Research Hospital of Ataturk University.
💡
Conclusion & Impact:The D zone test, which can be done by using erythromycin and clindamycin discs, is a simple disc diffusion test for detection MLSB phenotype and clinical laboratories should report in vitro inducible clindamycin resistance in all S. aureus isolates.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Clindamycin is one of the important alternative antibiotics in the therapy of Staphylococcus aureus infections. The limited treatment options for MRSA, increaes the importance of the right antibiotic.The major problem of the use of clindamycin for such infections is the presence of inducible clindamycin resistance that can lead to treatment failure. The aim of this study was to investigate the inducible clindamycin resistance of 86 MRSA strains isolated from Research Hospital of Ataturk University. Inducible clindamiycin resistance was detected using D zone test method according to Clinical and Laboratory Standards Institute (CLSI) instructions. Twenty of the strains exhibited the iMLSB, 8 exhibited the cMLSB and 22 exhibited the MS phenotype. The D zone test, which can be done by using erythromycin and clindamycin discs, is a simple disc diffusion test for detection MLSB phenotype and clinical laboratories should report in vitro inducible clindamycin resistance in all S. aureus isolates.

🔖

Cite This Article

HANCI, H., AYYILDIZ, A., İGAN, H. (2017). Investigation of inducible clindamycin resistance in methicillin resistant Staphylococcus aureus strains. Marmara Pharmaceutical Journal, Cilt: 21 - Sayı: 2, 407–411. https://ajindex.com/articles/283725

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Farooq S, Saleem M. Prevalence of constıtutıve and inducıbleclindamycin resıstance among clinical isolates of Staph aureusin Kashmir valley: a hospital based study. J Evolution MedDent Sci 2016;5:828-31.
  2. Uyanik MH, Yazgi H, Bilici D, Ozden K, Karakoc E. Detectionof macrolide-lincosamide-streptogramin B resistance innosocomial Staphylococcus aureus strains. Ankem Derg2009;23:66-70.
  3. Mittal V. Kishore S, Siddique ME. Prevalence of inducibleclindamycin resistance among clinical isolates ofStaphylococcus aureus detected by phenotypic method: Apreliminary report. J Infect Dis Immun 2013;51:10-2.
  4. Shittu A, Oyedara O, Abegunrin F, Okon K, Raji A, TaiwoS, Ogunsola F, Onyedibe K, Elisha G. Characterization ofmethicillin-susceptible and resistant staphylococci in theclinical setting: a multicentre study in Nigeria. BMC InfectDis 2012; 12:286. Vural A, Afşar İ, Kurultay N, Demirci M. Comparison of diskdiffusion, oxacillin agar screening, microdilution and pbp2alatex agglutination tests for detection of methicillin resistancein Staphylococcus aureus. Ankem Derg, 2011;25:145-9.
  5. Şamlıoğlu P, Ece G, Atalay S, Kose Ş. Macrolide-lincosamidestreptograminB (MLSB) resistance phenotypes instaphylococci isolated from clinical samples. Ankem Derg2012;26:116-9.
  6. Tekin A, Dal T, Deveci O, Tekin R, Atmaca S, Dayan S.Assessment of methicillin and clindamycin resistance patternsin Staphylococcus aureus isolated from a tertiary hospital inTurkey. Infez Med 2013;2:111-6. CLSI. Performance standards for antimicrobial susceptibilitytesting; twentysecond informational supplement. M100-S22.Wayne, PA: Clinical and Laboratory Standards Institute; 2012.
  7. Shoji K, Shinjoh M, Horikoshi Y, Tang J, Watanabe Y, SugitaK, Tame T, Iwata S, Miyairi I, Saitoh A. High rate of inducibleclindamycin resistance in Staphylococcus aureus isolates-A multicenter study in Tokyo, Japan. J Infect Chemother2015;21:81-3. Lewis JS 2nd, Jorgensen JH. Inducible clindamycin resistancein Staphylococci: should clinicians and microbiologists beconcerned? Clin Infect Dis 2005;40:280-5.
  8. Sasirekha B, Usha MS, Amruta JA, Ankit S, Brinda N, Divya R.Incidence of constitutive and inducible clindamycin resistanceamong hospital-associated Staphylococcus aureus. 3 Biotech2014;4:85–9. Sancak B. Staphylococcus aureus and antibiotic resistanceMikrobiyol Bul 2011;45: 565-76.
  9. Doğan M, Feyzioğlu B, Baykan M. The change of antibioticresistance in S. aureus strains within ten year periods. AbantMed J 2014;3:237-41.
  10. Gungor S, Uzun BK, Yurtsever